Skip to content
‹ Back to IndustriesSciences

Denali Water Solutions, LLC Acquires Stock of Veris Environmental, LLC and AWS Dredge, LLC

Russellville, Arkansas – October 26, 2020 – Denali Water Solutions, LLC announced that it has acquired the stock of Veris Environmental, LLC and AWS Dredge, LLC. Veris Environmental, LLC is a residuals management services company providing biosolids recycling and transportation, dewatering, digester cleaning, lagoon services and sediment removal, and land application services in the western…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Aws DredgeDenaliJay HolmesLiquid Waste Management
Share
Denali Water Solutions, LLC Acquires Stock of Veris Environmental, LLC and AWS Dredge, LLC

Key takeaways

01

Russellville, Arkansas – October 26, 2020 – Denali Water Solutions, LLC announced that it has acquired the stock of Veris Environmental, LLC and AWS Dredge, LLC.

02

Veris Environmental, LLC is a residuals management services company providing biosolids recycling and transportation, dewatering, digester cleaning, lagoon services and sediment removal, and land application services in the western…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Russellville, Arkansas – October 26, 2020 – Denali Water Solutions, LLC announced that it has acquired the stock of Veris Environmental, LLC and AWS Dredge, LLC. Veris Environmental, LLC is a residuals management services company providing biosolids recycling and transportation, dewatering, digester cleaning, lagoon services and sediment removal, and land application services in the western United States. AWS Dredge, LLC, is a service provider to hard rock mines in the western United States. The stock purchase aligns with Denali’s strategic growth plan of expansion to additional markets and geographical regions.

“We are thrilled to welcome the Veris Environmental and AWS Dredge teams to the Denali family. This decision aligns with our goal of building a team with strong and experienced leaders to enhance our safety-focused and quality residuals management services to our customers and to the communities we live and work in,” noted Andy McNeill, CEO of Denali Water Solutions.

Kipp Parker, the majority owner of Veris Environmental and founder of Parker Ag Services, stated that he is grateful to have formed a relationship with Denali Water Solutions and is looking forward to seeing the expansion of the stewardship of the company he has built over the years.

Jay Holmes, CEO of Veris Environmental and founder of Liquid Waste Management, and Mike Scharp, Vice President of Marketing and Technical Services of Veris Environmental and a long term partner in Parker Ag Services, have both expressed excitement about joining the Denali Water Solutions leadership team as Denali expands their market area into the Rocky Mountain region of the United States.

About Denali Water Solutions

Denali Water Solutions is a specialty waste and environmental services company that believes it is the collective responsibility of us all to protect the quality of water and natural resources through recycling waste in sustainable ways, can be beneficially reused, and reduce or eliminate the use of landfills. Our vision is to meet this responsibility by offering innovative and economically effective solutions for the management, handling, recycling, disposal, and conversion of organic waste materials through beneficial reuse, composting, and anaerobic digestion for the customers and communities we serve. Denali Water Solutions is a full-service provider throughout the organic waste management cycle; processed waste is dewatered then recycled through liquid and solid land applications, chemical treatment, and composting. Beneficial use and recycling methods create sustainability benefits through fertilizing farmland, enhancing soil health with compost, and generating clean water. To learn more, please visit here.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Clinical data harmonization is the bottleneck for life sciences AI

Clinical data harmonization is the bottleneck for life sciences AI

Life sciences companies moving AI from experimentation to scale keep running into messy trial data. One study can draw on EDC, health records, eCOA tools, wearables and imaging, and data teams at pharma SMEs often spend up to 80% of their time wrangling it. Commentators point to lakehouse architectures and data-cleansing AI agents, though the agents are still at proof of concept.

  • 01Treat automation gains as proof-of-concept for now; evaluate AI/harmonization choices based on data readiness, governance, and whether the architecture supports traceability and regulatory needs.

Sep 26, 2026

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

Contract Pharma reports bioTRAK data projecting CDMOs will install roughly 120 bioreactors by 2030. It says 71% of added volume is large-scale stainless steel, while 61% of systems are single-use.

  • 01Utilization discipline is still driving builds: BioTRAK’s Dawn Ecker told Contract Pharma expansion conversations typically start after a site is booked above ~80% for several years.

Sep 22, 2026

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512